Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Alzheimer's Disease: Advances for a New Century
Guest editors: George Perry, Xiongwei Zhu, Mark A. Smith, Aaron Sorensen and Jesús Avila
Article type: Review Article
Authors: Watt, Andrew D.a; b | Villemagne, Victor L.c; d | Barnham, Kevin J.b; c; e; *
Affiliations: [a] Department of Pathology, The University of Melbourne, Parkville, Melbourne, VIC, Australia | [b] Neuroproteomics Platform, Bio21 Molecular Science and Biotechnology Institute, VIC, Australia | [c] Mental Health Research Institute, The University of Melbourne, Parkville, Melbourne, VIC, Australia | [d] Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, VIC, Australia | [e] Department of Pharmacology, The University of Melbourne, Parkville, Melbourne, VIC, Australia
Correspondence: [*] Correspondence to: Kevin J. Barnham, MHRI and Department of Pharmacology, The University of Melbourne, VIC 3010, Australia. Tel.: +61 3 83442555; Fax: +61 3 93476750; E-mail: [email protected].
Abstract: Over the past 100 years, there has been an exponential increase in our understanding of the underlying pathology of Alzheimer's disease (AD). This growth in knowledge has largely stemmed from the intensification of research into AD which has occurred over the past three decades and the incorporation of the amyloid cascade hypothesis as the generally accepted dogma of AD pathogenesis. While at times contentious, the notion that AD arises from aberrations in amyloid-β (Aβ) production and degradation has led to a number of significant breakthroughs in the way in which AD is currently diagnosed and in the attempts at disease modifying therapies, from investigations into the underlying factors mediating the aggregation of Aβ to the development of therapeutic strategies and measures of neuroimaging allowing Aβ burden to be monitored within the AD-affected brain. This review focuses on some of the recent work we have conducted toward elucidating the role of Aβ in AD.
Keywords: Biomarker, blood, copper, mass spectrometry, metal chaperone, NMDA, toxicity, zinc
DOI: 10.3233/JAD-2012-129017
Journal: Journal of Alzheimer's Disease, vol. 33, no. s1, pp. S283-S293, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]